Imatinib as a cause of cystoid macular edema following uneventful phacoemulsification surgery.
Cystoid macular edema (CME) is an important cause of visual impairment following phacoemulsification surgery. Imatinib is a new drug that is being used as adjunctive therapy in the management of various malignancies. A reported ocular side effect of this drug is spontaneous retinal edema. We report the case of a patient on imatinib who developed significant premature CME following uneventful phacoemulsification surgery. This resolved soon after cessation of imatinib therapy, and there was an improvement in visual acuity.
Masood
Imran
I
Division of Ophthalmology, Queens Medical Centre, Nottingham, United Kingdom. imranmasood777@gmail.com
Negi
Anil
A
Dua
Harminder S
HS
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001549:Benzamides; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D010879:Piperazines / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D041623:Tomography, Optical Coherence
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate